NYSE · IFF
International Flavors & Fragrances Inc.
$90.81+$0.15 (+0.17%)
International Flavors & Fragrances Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.06% below the high.
Loading market information…
NASDAQ · BCPC · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Balchem Corp’s quoted price sits in the upper half of its reported 52-week range, 7.34% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Balchem Corp’s forward annual dividend is $0.96 per share, paid annual. The forward yield is 0.56% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Balchem Corp’s next earnings report is currently expected on Feb 19, 2027, with estimated earnings per share of $1.41. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Balchem Corp’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:03 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 |
|---|
| Jul 31, 2025 |
| $1.27+1.6% vs estimate |
| $255.47M-0.85% vs estimate |
| Q1 2025 | Apr 24, 2025 | $1.22-2.4% vs estimate | $250.52M+1.96% vs estimate |
|---|
| Q4 2024 | Feb 21, 2025 | $1.03-7.21% vs estimate | $240.00M-2.0% vs estimate |
|---|
THE ANALYST VIEW
10 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 2 contributors · Median target $212.50.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$90.81+$0.15 (+0.17%)
International Flavors & Fragrances Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.06% below the high.
$67.93+$1.26 (+1.89%)
Eastman Chemical Company’s quoted price sits in the lower half of its reported 52-week range, 18.62% below the high.
$95.59+$1.34 (+1.42%)
Ingredion Incorporated’s quoted price sits in the lower half of its reported 52-week range, 22.59% below the high.
$131.53-$0.06 (-0.05%)
Sensient Technologies Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.25% below the high.
$42.88+$0.69 (+1.64%)
Avient Corporation’s quoted price sits in the upper half of its reported 52-week range, 8.06% below the high.
$74.38+$1.71 (+2.35%)
Ashland Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.95% below the high.
$153.73-$0.33 (-0.21%)
Hawkins, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.71% below the high.
$49.69+$0.34 (+0.69%)
H.B. Fuller Company’s quoted price sits in the lower half of its reported 52-week range, 27.6% below the high.
